Dr. Muhammad Furqan, MD
- Medicare services, 2024
- 718
- Medicare patients, 2024
- 234
- Part D claims, 2024
- 1,267
- Publications
- 77
- Clinical trials
- 10
- Practice address
- 1200 Childrens Ave, Oklahoma City, OK 73104
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Ou Medical Center-The Children's Ho - Rad CT - HOPD
Acute Care Hospital outpatient department · Oklahoma City, Oklahoma
Find Dr. Furqan's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Muhammad Furqan is a medical oncologist in Oklahoma City, Oklahoma
Dr. Furqan practices at Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma.
Dr. Furqan's NPI, 1306090220, was assigned on November 5, 2008. Dr. Furqan holds Iowa license MD-41701.
- NPI
- 1306090220NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3678796281
- NPI enumeration date
- November 5, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 47
- Medical school graduation
- 2005
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Muhammad Furqan practices at Ou Medical Center-the Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma
Dr. Furqan's primary practice is Ou Medical Center-the Children's Ho - Rad CT - HOPD, at 1200 Childrens Ave, Oklahoma City, OK 73104.
- Ou Medical Center-the Children's Ho - Rad CT - HOPD1200 Childrens Ave, Oklahoma City, OK 73104
Source: Dmand AI Affiliation Data
Dr. Muhammad Furqan is affiliated with 4 sites of care and 1 medical group
Dr. Furqan's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dr. Furqan is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is OU Health. Dmand AI also links Dr. Furqan to 1 more hospital and 1 group practice or clinic, each named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Muhammad Furqan's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Furqan practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Ou Medical Center-The Children's Ho - Rad CT - HOPD | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Muhammad Furqan is one of 10 medical oncologists in Oklahoma
Medical oncology is Dr. Furqan's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Furqan is licensed in Iowa.
Specialties and state licenses
- Medical oncology, IowaPrimary
Medical oncologists near Dr. Furqan
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Muhammad Furqan billed Medicare for 718 services in 2024
CMS data shows 718 Medicare services from Dr. Furqan across 3 procedure codes in 2024, all of them office visits, for 234 Medicare patients. Medicare paid $55,405 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Furqan's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 5652024: 71827%
Dr. Furqan's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Furqan?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Furqan and other medical oncologists in Oklahoma.
Source: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data
Dr. Muhammad Furqan treated 234 Medicare patients in 2024, average age 73
CMS counts 234 Medicare patients who saw Dr. Furqan in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have cancer, and 70% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Furqan's median patient age at 73, with 56% women.
Dr. Furqan's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Furqan's Medicare patients by sex, 2024
- Women13558%
- Men9942%
Chronic conditions among Dr. Furqan's Medicare patients, 2024
- Cancer75%
- High cholesterol70%
- High blood pressure69%
- COPD52%
- Tobacco use35%
- Anxiety33%
- Arthritis29%
- Ischemic heart disease28%
Share of Medicare patients with each condition. A patient can have several.
Dr. Furqan's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women56%
- Men44%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Muhammad Furqan wrote 1,267 Medicare Part D claims in 2024
In 2024, Dr. Furqan wrote 1,267 Medicare Part D claims for 173 patients. 79% of them were for generic drugs. CMS names the drug for 1,027 of them, across 25 drugs with 11 or more claims each, at $925,975 in total drug cost. In 2023, CMS named 822 claims across 27 drugs.
Dr. Furqan's Part D claims by kind of drug, 2024
- Generic998 claims79%
- Brand-name269 claims21%
Dr. Furqan's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Furqan's Part D claims, 2024
- Opioids8%96 of 1,267 claims
- Antibiotics3%35 of 1,267 claims
- Antipsychotics, patients 65 and over10%122 of 1,267 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 8222024: 1,02725%
Drugs named by CMS: 25 in 2024, 27 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Muhammad Furqan scored 80 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Furqan for performance year 2024, reported as part of a group. Dr. Furqan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Furqan's MIPS scores, performance year 2024
- 80of 100Final score
- 75.7of 100Quality
- 78of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Muhammad Furqan has 77 publications on record
Dmand AI links 77 papers to Dr. Furqan, published from 2013 to 2025. 2024 was the busiest year, with 12. The most frequent topics are Lung Neoplasms, Antineoplastic Agents and Carcinoma, Non-Small-Cell Lung. Dr. Furqan has published most often in Transl Lung Cancer Res. Dr. Furqan's most frequent co-authors are Allan L. Klein, MD, Gerald H. Clamon, MD and Beni R. Verma, MD.
Dr. Furqan's papers by year, 2016 to 2025
Topics Dr. Furqan writes about most
- Lung Neoplasms
- Antineoplastic Agents
- Carcinoma, Non-Small-Cell Lung
- Pericarditis
- Antineoplastic Combined Chemotherapy Protocols
- Immunotherapy
- Cell Line, Tumor
- Pericardial Effusion
Dr. Furqan's most frequent co-authors
- Allan L. Klein, MD15 shared papers
- Gerald H. Clamon, MD10 shared papers
- Beni R. Verma, MD9 shared papers
Recent publications by Dr. Furqan
See who Dr. Furqan researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Furqan works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Muhammad Furqan has worked on 10 clinical trials
Dmand AI links Dr. Furqan to 10 clinical trials, 5 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Lung Neoplasms. National Cancer Institute (NCI) sponsors the most, 5.
Clinical trials with Dr. Furqan by phase
- NonePhase 1: no trials
- 4Phase 2: 4 trials
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Conditions in Dr. Furqan's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Lung Neoplasms
- Thoracic Neoplasms
- Genomic Instability
Investigators on the most trials with Dr. Furqan
- Cheryl M. Czerlanis, MD6 shared trials
- Linda L. Garland, MD6 shared trials
- Firas Benyamine Badin, MD5 shared trials
Recent clinical trials with Dr. Furqan
A Phase 2 Trial of Pharmacological Ascorbate With Concurrent Chemotherapy and Radiation Therapy for Non-small Cell Lung Cancer (opens in a new tab)
QUILT-3.055: A Phase IIb, Multicohort, Open-Label Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors (opens in a new tab)
Alleviation by NIAGEN of Persistent Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors (opens in a new tab)
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (opens in a new tab)
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Muhammad Furqan received $13,872 in industry payments from 2016 to 2025
CMS Open Payments shows 22 general payments to Dr. Furqan from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. AstraZeneca Pharmaceuticals LP paid the most, $4,820. It also lists 1 research payment totaling $190 in 2018.
General payments to Dr. Furqan by program year, 2016 to 2025
General payments to Dr. Furqan by kind, 2016 to 2025
- Consulting fees$10,73577%
- Travel and lodging$2,82020%
- Food and beverage$2262%
- Education$911%
Companies that paid Dr. Furqan the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Muhammad Furqan's profile data
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Muhammad Furqan
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Muhammad Furqan's NPI number?
Dr. Muhammad Furqan's NPI number is 1306090220. It was assigned on November 5, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Muhammad Furqan?
Dr. Muhammad Furqan is a medical oncologist in Oklahoma City, Oklahoma. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Muhammad Furqan practice?
Dr. Furqan practices at 1200 Childrens Ave, Oklahoma City, OK 73104. Dr. Furqan's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dmand AI also links Dr. Furqan to 1 hospital and 1 group practice or clinic.
What is Dr. Muhammad Furqan's medical license number?
Dr. Furqan holds Iowa license MD-41701.
Which hospitals is Dr. Muhammad Furqan affiliated with?
Dr. Furqan is affiliated with OU Health University of Oklahoma Medical Center. Dmand AI links Dr. Furqan to 1 more hospital.
What medical group is Dr. Muhammad Furqan part of?
Dr. Furqan is linked to OU Health.
Does Dr. Muhammad Furqan accept Medicare?
Yes. CMS data shows Dr. Furqan billed Medicare for 718 services in 2024, and Dr. Furqan accepts Medicare assignment.
What is Dr. Muhammad Furqan's MIPS score?
Dr. Furqan's MIPS final score for performance year 2024 is 80 out of 100, reported as part of a group.
How many Medicare patients does Dr. Muhammad Furqan see?
CMS counts 234 Medicare patients who saw Dr. Furqan in 2024, with an average age of 73.
What services does Dr. Muhammad Furqan bill to Medicare?
In 2024, Dr. Furqan's most billed Medicare services were office visit, established patient (99214), office visit, new patient (99205) and office visit, established patient (99215).
Show 5 more questionsShow fewer questions
What drugs does Dr. Muhammad Furqan prescribe most?
In 2024 Medicare Part D data, Dr. Furqan's most prescribed drugs by claims were Olanzapine, Prochlorperazine Maleate and Ondansetron HCl.
Has Dr. Muhammad Furqan received payments from drug or device companies?
CMS Open Payments shows $13,872 in general payments to Dr. Furqan from 8 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Muhammad Furqan been practicing?
Dr. Furqan graduated from medical school in 2005, 21 years ago.
Does Dr. Muhammad Furqan do research?
Dmand AI links 77 publications to Dr. Furqan, published from 2013 to 2025. Dr. Furqan has worked on 10 clinical trials.
Who does Dr. Muhammad Furqan publish with?
Dr. Furqan's most frequent co-authors are Allan L. Klein, MD (15 shared papers), Gerald H. Clamon, MD (10 shared papers) and Beni R. Verma, MD (9 shared papers).
Selling to medical oncology practices?
See medical oncologists in Oklahoma by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card